Stock PAR PARADIGM BIOPHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Paradigm Biopharmaceuticals Limited

Equities

PAR

AU000000PAR5

Delayed Australian S.E.
Other stock markets
 01:27:03 2024-05-01 am EDT 		5-day change 1st Jan Change
0.29 AUD +7.41% Intraday chart for Paradigm Biopharmaceuticals Limited +1.75% -31.76%
Apr. 19 Paradigm Biopharmaceuticals Submits Documents to FDA for Phase 3 Osteoarthritis Program MT
Feb. 28 Paradigm Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Evolution of the average Target Price on Paradigm Biopharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

104e.Q0Tj4vAd-_N0JOLOT4DO7oxikFOin1x5PJ5zdgr_vUc.BSCGz5ZuvYAOF5uGIeX7rdVWoB6WsgQ6DsgWOFu67h96JZLaskrCtExwiQ~f3acd0f3fc1a13c78010363c8bef32dd

Analyst Recommendations on Paradigm Biopharmaceuticals Limited

Lingering Concerns on Economic Outlook, Rate Hikes Dampen Appetite for Australian Shares MT
Australian Shares Rise to One-Month High After US Fed Rate Hike MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.27 AUD
Average target price
2.295 AUD
Spread / Average Target
+750.00%
High Price Target
3.19 AUD
Spread / Highest target
+1,081.48%
Low Price Target
1.4 AUD
Spread / Lowest Target
+418.52%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PAR Stock
  4. Consensus Paradigm Biopharmaceuticals Limited